Vasopressin is a systemic vasoconstrictor. Its pulmonary vasodilatory effect is controversial, and limited data are available on its use in neonates with pulmonary hypertension. Hypothesizing that the ...

Patients with vasodilatory shock, characterized by peripheral vasodilatation and low arterial blood pressure, who do not respond to vasopressors (catecholamines or vasopressin) have a poor prognosis.

Vasodilatory shock is a life-threatening syndrome that requires immediate treatment; conventional vasopressors have a narrow therapeutic window and toxicities at high doses. New research findings are ...